Rabindra Braganza, MD
Otolaryngology · Santa Barbara, CANPI 1972512382
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,054 of the $3,262 with a category attached, or 63.0%. Intersect ENT, Inc. accounts for 81.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $2,939 and has fallen 93.3% since, to $197 in 2025.
Across 25 payments — averaging $130.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Regeneron Healthcare Solutions, Inc.$190
- ARS Pharmaceuticals Operations, Inc.$138
- Sanofi$122
- Stryker$50
- GSK$31
- plus $73 from 4 others
What the payments were for
- Travel & lodging$2,05463%
- Food & beverage$1,20937%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 12 | $2,658 |
| Regeneron Healthcare Solutions, Inc. | 3 | $190 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $138 |
| Sanofi | 2 | $122 |
| Stryker | 2 | $50 |
| GSK | 1 | $31 |
| Optinose US, Inc. | 1 | $22 |
| Olympus America Inc. | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,262 in reported general payments places this provider in the 75th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 180 | $2,730 |
| Famotidine | 291 | $2,561 |
| Budesonide | 11 | $2,305 |
| Azelastine Hcl | 61 | $1,757 |
| Ipratropium Bromide | 40 | $1,656 |
| Omeprazole | 86 | $689 |
| Montelukast Sodium | 36 | $538 |
| Ciprofloxacin Hcl | 24 | $214 |
| Acetic Acid | 11 | $208 |
| Pantoprazole Sodium | 17 | $185 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $178 |
| Methylprednisolone | 18 | $152 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 19 | $134 |
| CefuroximeCefuroxime Axetil | 11 | $127 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $126 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Santa Barbara
- Brian WeeksSan Diego$924K
- Randall OwRoseville$613K
- Amir MoradiVista$389K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
- Todd MillerNewport Beach$259K
- Jeffrey SuhLos Angeles$223K
- Dennis TangLos Angeles$209K
- Jeffrey FeinfieldThousand Oaks$160K
- Jonathan SykesGranite Bay$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.